Bielekova; Bibiana

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bielekova; Bibiana.The latest application filed is for "biomarkers for diagnosis and management of neuro-immunological diseases".

Company Profile

4.10.17

Bielekova; Bibiana - Kensington MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biomarkers for diagnosis and management of neuro-immunological diseases Grant 10,877,049 - Bielekova , et al. December 29, 2	2020-12-29
Biomarkers For Diagnosis And Management Of Neuro-immunological Diseases App 20190265254 - Bielekova; Bibiana ; et al.	2019-08-29
Biomarkers for diagnosis and management of neuro-immunological diseases Grant 10,261,098 - Bielekova , et al.	2019-04-16
Method For The Treatment Of Multiple Sclerosis App 20190002575 - Martin; Roland ; et al.	2019-01-03
Method For The Treatment Of Multiple Sclerosis App 20180237532 - MARTIN; Roland ; et al.	2018-08-23
Biomarkers For Diagnosis And Management Of Neuro-immunological Diseases App 20170242043 - Bielekova; Bibiana ; et al.	2017-08-24
Method For The Treatment Of Multiple Sclerosis App 20170190779 - MARTIN; Roland ; et al.	2017-07-06
Methods for the Treatment of Multiple Sclerosis App 20150337044 - Martin; Roland ; et al.	2015-11-26
Method for the Treatment of Multiple Sclerosis App 20150010477 - Martin; Roland ; et al.	2015-01-08
Method Of Treating Multiple Sclerosis By Intrathecal Depletion Of B Cells And Biomarkers To Select Patients With Progressive Multiple Sclerosis App 20140234307 - Bielekova; Bibiana ; et al.	2014-08-21
Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist Grant 8,636,997 - Martin , et al. January 28, 2	2014-01-28
Method for the treatment of multiple sclerosis Grant 8,454,965 - Martin , et al. June 4, 2	2013-06-04
Method Of Treating Autoimmune Diseases With Interferon-beta And Il-2r Antagonist App 20130095069 - Martin; Roland ; et al.	2013-04-18
Method For The Treatment Of Multiple Sclerosis App 20130017152 - MARTIN; Roland ; et al.	2013-01-17
Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist Grant 8,298,525 - Martin , et al. October 30, 2	2012-10-30
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis Grant 8,293,800 - Meier , et al. October 23, 2	2012-10-23
Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone For The Treatment Of Primary Progressive Multiple Sclerosis App 20100280130 - Meier; Thomas ; et al.	2010-11-04
Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist Grant 7,575,742 - Martin , et al. August 18, 2	2009-08-18
Method Of Treating Autoimmune Diseases With Interferon-beta And Il-2r Antagonist App 20090175823 - Martin; Roland ; et al.	2009-07-09
Method for the treatment of multiple sclerosis App 20080038275 - Martin; Roland ; et al.	2008-02-14
Method for the treatment of multiple sclerosis Grant 7,258,859 - Martin , et al. August 21, 2	2007-08-21
Method of treating autoimmune diseases with interferon-beta and il-2r antagonist App 20050249704 - Martin, Roland ; et al.	2005-11-10
Method for the treatment of multiple sclerosis App 20040109859 - Martin, Roland ; et al.	2004-06-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.